Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wenzel Spine is a private U.S. medical device company focused on minimally invasive spinal surgery technologies rather than therapeutics. The company develops and markets stand-alone expandable interbody fusion and fixation systems intended for cervical, lumbar, and sacroiliac procedures. Its core commercial franchise includes the VariLift family and related spine implants designed to simplify procedures, reduce hardware burden, and support outpatient or ambulatory surgery settings. Wenzel positions its products around less invasive spine care, procedural efficiency, and reduced recovery burden for patients with degenerative spine conditions. The company appears to be an active commercial-stage medtech business, not a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wenzel.